ClinicalTrials.Veeva

Menu

Effect of Vitamin D on the Size of Fibroids in Women With Vitamin D Deficiency

F

Fundación IVI

Status

Completed

Conditions

Size of the Uterine Fibroids

Study type

Observational

Funder types

Other

Identifiers

NCT03991078
IIS-COL-2018-01
1812-FIVI-100-AP (Registry Identifier)

Details and patient eligibility

About

Vitamin D supplementation in patients with uterine fibroids who present hypovitaminosis D to re-establish their normal serum values could stabilize the size of the uterine fibroids and thus prevent their growth or reduce their size thanks to the anti-proliferative action of Vitamin D on the myoma cells.

Enrollment

15 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with at least one fibroid > 3 cm
  • With hypovitaminosis D (25(OH)D < 30 ng/ml)
  • BMI < 30
  • No hormonal treatment in the 3 months prior to the ultrasound study

Exclusion criteria

  • Black race
  • Symptomatic fibroids subsidiary to hormonal or surgical treatment
  • Desire of gestation in the next 6 months
  • Presence of degenerating adenomyosis or fibroids
  • Treatment with sexual hormones: mifepristone, aGnRH or any other medication that may interfere with fibroids.
  • History of neoplasia of gynecological origin and/or existence of uterine malformations.
  • Hypercalcemia or abnormal liver or kidney function is present

Trial contacts and locations

1

Loading...

Central trial contact

Hortensia Ferrero, phD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems